AUGUSTA, Ga. (April 24, 2012) – CURE Childhood Cancer’s Press On Fund will be featured on Cole Whitt’s No. 88 TaxSlayer.com Chevrolet in NASCAR Nationwide Series events at Richmond International Raceway and Darlington Raceway as part of a collaborative effort by TaxSlayer and JR Motorsports to raise awareness in the fight against childhood cancer.
The logo of Press On Fund will appear on the TV panel of the No. 88 TaxSlayer.com Chevrolet starting this weekend at Richmond. The Virginia 529 College Savings 250 is scheduled for a 7 p.m. ET start on ESPN2. It will appear for a second time on Whitt’s car at Darlington for the May 11th VFW Sport Clips Help A Hero 200. That race will start at 6:30 p.m. ET on ESPN2.
The Press On Fund’s goal is two-fold: to achieve a greater cure rate for pediatric neuroblastoma and AML, which represents the two childhood cancers with the lowest survival rates. It also aims to mitigate the potentially devastating side effects of current therapies.
“This is something we are doing to help draw attention towards two devastating forms of childhood cancer and the race to a CURE for all childhood cancer,” said Daniel Eubanks, motorsports director for TaxSlayer.com. “At TaxSlayer we are great friends with some of the founders of this fund, and we are trying to do everything that we can to help. Press On donates 100% of its funding towards research. The significance of these dollars for the children that need them most cannot be underscored.”
Press On Fun is a named fund of CURE Childhood Cancer, a 501(c)(3) with a long standing reputation for its commitment to supporting families and finding a CURE. To accomplish its goals, the Press On Fund provides grants to scientists and institutions conducting research into novel, targeted therapies for neuroblastoma and AML. In just under three years the Press On Fund has invested more than $770,000 to save children’s lives.
For more information on Press On Fund, please visit its website at www.pressonfund.org.
Jr Motorsports No. 88 Chevy to Feature Childhood Cancer Initiative
